Frequently asked questions
How this atlas selects entries, grades evidence, verifies claims, and communicates updates.
Questions
What is the Peptides Community atlas?
It is a source-traceable research atlas covering peptide identity, evidence, safety signals, and regulatory status. Inclusion reflects scientific, clinical, regulatory, or public visibility and is not an endorsement of a substance or product.
How does the atlas grade evidence?
The atlas grades each precise indication-specific claim from established evidence through preliminary human, preclinical, or marketing-only support, with a separate grade for contradictory evidence. A grade applies to the claim, not to the molecule as a whole.
Is the atlas medical advice?
No. The atlas is a research synthesis and does not provide individualized medical advice. Product status depends on the indication and jurisdiction, and research-use material must not be assumed safe, sterile, authentic, or suitable for humans.
Does the atlas recommend products or sellers?
No. Commercial listings may document that a claim or blend is marketed, but they cannot establish efficacy, safety, purity, or legal status. The atlas does not provide purchasing guidance or treat marketing claims as scientific evidence.
How does the atlas verify claims?
Researchers prioritize current official records, product information, trial registries, and primary studies. Pages record search dates, identifiers, limitations, and source links. Approval, trial, sport, and legal-status claims are treated as time-sensitive and should be rechecked before decisions.
How can I join atlas updates?
Use the Join page to submit an email address. Updates are concise notes sent when peptide evidence, status, or source records change.